Stock listing

Kuros Biosciences Ltd.

Selected listing: A2ALS5 · LSX · EUR · DE

Kuros Biosciences Ltd. (LS Exchange: A2ALS5), Health Technology. Latest release Aug 13, 2026: Kuros Biosciences delivers 45% H1 2026 year-over-year sales…

A2ALS5:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A2ALS5
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LS Exchange
Currency: EUR

About Kuros Biosciences Ltd.

Kuros Biosciences Ltd. (ticker: KURN) is a public company based in Switzerland, focused on developing innovative therapies in the field of regenerative medicine. The company aims to leverage its expertise in biomaterials and tissue regeneration to improve patient outcomes.

Latest news from Kuros Biosciences Ltd.

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

August 13, 2026

Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth

May 7, 2026

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

April 14, 2026

Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025

March 10, 2026

Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences

January 13, 2026

All Kuros Biosciences Ltd. news →

Research Kuros Biosciences Ltd.

Kuros Biosciences Ltd. company profile

View the public company page for Kuros Biosciences Ltd. on 6ix.

Kuros Biosciences Ltd. news

Read company news and market updates connected to Kuros Biosciences Ltd..

Kuros Biosciences Ltd. investor events

Find investor webinars, events, and replay context for Kuros Biosciences Ltd..